CYP3A5 and ABCB1 Polymorphisms as Predictors for Sunitinib Outcome in Metastatic Renal Cell Carcinoma

Author(s):
Diekstra, M.H.M.; Swen, J.J.; ; Castellano, D.; Gelderblom, H.; Mathijssen, R.H.J.; Rodriguez-Antona, C.; Garcia-Donas, J.; Rini, B.I.; Guchelaar, H.J. (0000-0002-7085-1383)
Published
2015
Publication type
Article / Letter to editor
SunitinibPharmacogeneticsMetastatic renal cell carcinomaSingle nucleotide polymorphismBiomarkerAssociation analysis
Date issued
2015-10-31
Language
English
Is part of
European Urology (2015), Vol. 68, no. 4, p. 621-629
hdl
1887/107400
doi
10.1016/j.eururo.2015.04.018